Brief: Ascentage Pharma Group International Posts H1 Net Income Of HKD 163 Million
22/08/2024 15:25
Aug 22 (Reuters) - Ascentage Pharma Group International H1 revenue HKD 823.7 million. * H1 net income HKD 163 million
Recent news on Ascentage Pharma International
See all newsBrief: Ascentage Pharma Group Says Lisaftoclax Granted Breakthrough Therapy Designation In China
China's Ascentage Pharma climbs as chairman buys shares on market
Brief: Ascentage Pharma Group International's Chairman Buys 38,630 Shares
Brief: Ascentage Pharma Group International Posts H1 Net Loss Attributable RMB816.7 Million
China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-up